Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Zealand Pharma A/S
22ZCurrent price
123.5 EUR
+3.08 EUR (+2.57%)
Last closed
116.9 EUR
Company
–
ISIN
DK0060257814
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
7 945 988 412 EUR
Yield for 12 month
+231.28 %
1Y
3Y
5Y
10Y
15Y
22Z
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark. Address: Sydmarken 11, Søborg, Denmark, 2860
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
200.82 EURP/E ratio
–Dividend Yield
–Current Year
+45 742 580 EUR
Last Year
+13 876 180 EUR
Current Quarter
+4 554 535 EUR
Last Quarter
+2 013 518 EUR
Current Year
+43 183 948 EUR
Last Year
+13 876 180 EUR
Current Quarter
+3 288 297 EUR
Last Quarter
+1 400 081 EUR
Key Figures 22Z
1 year
3 years
5 years
10 years
EBITDA
-710 144 530 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-7.38 %
PEG Ratio
–
Return On Equity TTM
-12.8 %
Wall Street Target Price
200.82 EUR
Revenue TTM
366 392 981 EUR
Book Value
131.92 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
228 %
Dividend Yield
–
Gross Profit TTM
103 539 782 EUR
Earnings per share
-1.53 EUR
Diluted Eps TTM
-1.53 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-193.49 %
Dividend Analytics 22Z
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 22Z
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 22Z
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
136.4011
Price Sales TTM
21.6871
Enterprise Value EBITDA
-7.1603
Price Book MRQ
6.3363
Financials 22Z
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 22Z
For 52 weeks
36.6 EUR
129.84 EUR
50 Day MA
119.19 EUR
Shares Short Prior Month
–
200 Day MA
85.83 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart